Fundraising Fox

Qpexbio

San Diego, US · Founded 2018 · 2 known investors

qpexbio.com ↗

QPEX Bio develops anti-infective drugs targeting antibiotic-resistant bacterial and fungal pathogens. Its pipeline focuses on discovering new antibiotics for individual antimicrobial-resistant pathogens designated as serious or urgent threats.

BiotechHealthtechin /qpex-biopharma-inc@Qpexbio

Founders & leadership

MN
Michael N. DudleyExecutive Officer, Director
CG
Carol GallagherDirector
TG
Terry GouldDirector
KL
Kevin LiDirector
DB
Daniel BurgessDirector
DR
Douglas ReedDirector

Investors · 2

Hatteras Venture PartnersResearch Triangle · $500K – $4M
LYZZ CapitalShanghai

Reported raises · per SEC filings

Form D private placements
▶$27.4MraisedAug 2019 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael N. DudleyExecutive Officer, Director
  • Carol GallagherDirector
  • Terry GouldDirector
  • Douglas ReedDirector
  • Kevin LiDirector
  • Daniel BurgessDirector
Offering amount
$41.1M
Amount sold
$27.4M
First sale
Oct 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.